UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 294

Sortiert nach

ILAE Official Report: A practical clinical definition of epilepsy

Epilepsia (Copenhagen), 2014-04, Vol.55 (4), p.475-482

2014

Volltextzugriff (PDF)

NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson’s disease and controls

Neuroscience letters, 2015-05, Vol.594, p.36-39

2015

Volltextzugriff (PDF)

Recommendation for a definition of acute symptomatic seizure

Epilepsia (Copenhagen), 2010-04, Vol.51 (4), p.671-675

2010

Volltextzugriff (PDF)

Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study

Lancet neurology, 2012-08, Vol.11 (8), p.679-687

2012

Volltextzugriff (PDF)

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

JAMA neurology, 2015-10, Vol.72 (10), p.1175

2015

Volltextzugriff (PDF)

Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population-based study

Movement disorders, 2010-02, Vol.25 (3), p.341-348

2010

Volltextzugriff (PDF)

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects

Molecular bioSystems, 2016-01, Vol.12 (4), p.1287-1298

2016

Volltextzugriff (PDF)

Activities of daily living in Parkinson's disease: Time/gender perspective

Acta neurologica Scandinavica, 2020-02, Vol.141 (2), p.168-176

2020

Volltextzugriff (PDF)

Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease

Parkinsonism & related disorders, 2017-05, Vol.38, p.41-47

2017

Volltextzugriff (PDF)

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

Alzheimer's & dementia, 2015-12, Vol.11 (12), p.1407-1416

2015

Volltextzugriff (PDF)

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients

PloS one, 2011-04, Vol.6 (4), p.e18513-e18513

2011

Volltextzugriff (PDF)

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden

Neurobiology of aging, 2016-09, Vol.45 (212.e5), p.212.e5-212.e11

2016

Volltextzugriff (PDF)

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease

Journal of human genetics, 2015-07, Vol.60 (7), p.357-362

2015

Volltextzugriff (PDF)

Diffusion tensor imaging and correlations to Parkinson rating scales

Journal of neurology, 2013-11, Vol.260 (11), p.2823-2830

2013

Volltextzugriff (PDF)

A generic method for design of oligomer-specific antibodies

PloS one, 2014-03, Vol.9 (3), p.e90857-e90857

2014

Volltextzugriff (PDF)

Plasma-based circulating MicroRNA biomarkers for Parkinson's disease

Journal of Parkinson's disease, 2012, Vol.2 (4), p.321

2012

Volltextzugriff (PDF)

Plasma Metabolite Markers of Parkinson's Disease and Atypical Parkinsonism

Metabolites, 2021-12, Vol.11 (12), p.860

2021

Volltextzugriff (PDF)

The Effects of Working Memory Updating Training in Parkinson's Disease: A Feasibility and Single-Subject Study on Cognition, Movement and Functional Brain Response

Frontiers in psychology, 2021-01, Vol.11, p.587925-587925

2021

Volltextzugriff (PDF)

Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism

PloS one, 2014-12, Vol.9 (12), p.e113387-e113387

2014

Volltextzugriff (PDF)

Deep brain stimulation of the subthalamic nucleus versus the zona incerta in the treatment of essential tremor

Acta neurochirurgica, 2011-12, Vol.153 (12), p.2329-2335

2011

Volltextzugriff (PDF)

Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trial

BMC neurology, 2020-09, Vol.20 (1), p.337-14, Article 337

2020

Volltextzugriff (PDF)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients

Frontiers in neurology, 2021-02, Vol.11, p.620585

2021

Volltextzugriff (PDF)

Persistence of associations between cognitive impairment and motor dysfunction in the early phase of Parkinson’s disease

Journal of neurology, 2013-09, Vol.260 (9), p.2228-2236

2013

Volltextzugriff (PDF)

Incidence and Clinical Characterization of Unprovoked Seizures in Adults: A Prospective Population‐Based Study

Epilepsia (Copenhagen), 1996-03, Vol.37 (3), p.224-229

1996

Volltextzugriff (PDF)

Reoperation After Failed Deep Brain Stimulation for Essential Tremor

World neurosurgery, 2012-11, Vol.78 (5), p.554.e1-554.e5

2012

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ILAE Official Report: A practical clinical definition of epilepsy

NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson’s disease and controls

Recommendation for a definition of acute symptomatic seizure

Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population-based study

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects

Activities of daily living in Parkinson's disease: Time/gender perspective

Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease

Diffusion tensor imaging and correlations to Parkinson rating scales

A generic method for design of oligomer-specific antibodies

Plasma-based circulating MicroRNA biomarkers for Parkinson's disease

Plasma Metabolite Markers of Parkinson's Disease and Atypical Parkinsonism

The Effects of Working Memory Updating Training in Parkinson's Disease: A Feasibility and Single-Subject Study on Cognition, Movement and Functional Brain Response

Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism

Deep brain stimulation of the subthalamic nucleus versus the zona incerta in the treatment of essential tremor

Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trial

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients

Persistence of associations between cognitive impairment and motor dysfunction in the early phase of Parkinson’s disease

Incidence and Clinical Characterization of Unprovoked Seizures in Adults: A Prospective Population‐Based Study

Reoperation After Failed Deep Brain Stimulation for Essential Tremor

Suchergebnisse filtern